Received Apr 28, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (SHINGRIX) | GLAXOSMITHKLINE BIOLOGICALS | 3 | X5T42 | — |
accidentally gave an extra dose of Shingrix to a patient not realizing she already completed the 2 shot series in 2023..."; This non-serious case was reported by a physician via call center representative and described the occurrence of extra dose administered in a 50-year-old female patient who received Herpes zoster (Shingrix) (batch number X5T42, expiry date 30-JAN-2027) for prophylaxis. Previously administered products included Shingrix (received 2 doses in 2023). On 23-APR-2025, the patient received the 3rd dose of Shingrix. On 23-APR-2025, not applicable after receiving Shingrix, the patient experienced extra dose administered (Verbatim: accidentally gave an extra dose of Shingrix to a patient not realizing she already completed the 2 shot series in 2023..."). The outcome of the extra dose administered was not applicable. Additional Information: GSK Receipt Date: 23-APR-2025 The physician reported that a nurse accidentally gave an extra dose of Shingrix to a patient not realizing she already completed the 2 shot series in 2023, which led to extra dose administered. The vaccine administration facility was the same as primary reporter.